Showing: 1-20 of 1

Risperdal

Ark. judge affirms $181 million in legal fees

LITTLE ROCK, Ark. | An Arkansas judge says Johnson & Johnson must pay $181 million in fees to attorneys who successfully argued the pharmaceutical company committed Medicaid fraud in the marketing of its antipsychotic drug Risperdal.

February 01, 2013 4:44 pm
activate-button-3
Follow The Times

Featured Businesses

Poll

Loading…

Should struggling small school districts merge with their neighbors?

View Results